ben turner part 1- nataluzimab (tysabri), pml and jc virus
Published 14 years ago • 2.2K plays • Length 5:01Download video MP4
Download video MP3
Similar videos
-
3:05
ben turner part 3 - the pathophysiology of jc virus, pml and natiluzimab (tysabri)
-
4:51
ben turner part 2- looking for jc virus dna - is incidence related to tysabri?
-
5:37
ben turner part 4- the good news the effects of tysabri are reversible in ms patients.
-
6:27
evaluating natalizumab’s risk-benefit profile in ms
-
21:01
tysabri pml risk & extended interval dosing
-
3:44
rachel farrell part 1-neutralising antibodies to ifn - introduction
-
1:27
dr. maximilian timpte
-
13:29
jc virus mnemonic
-
4:58
beta cell therapies: replacement research in boston
-
1:14
dr victorio bambini jr. - one minute research
-
2:22
progressive multifocal leukoencephalopathy - (jc virus) - cerebrum brain treatment
-
28:35
update on pml
-
3:00
beta cell therapies: regeneration research in boston
-
2:40
why a diagnosis matters
-
5:04
klaus schmierer2 part 3- ms and ccsvi: an attempt to replicate findings, and media skew
-
20:56
110 ben zobrist & binomial probability introduction